Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra (resmetirom), ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through ... basal insulins – used to provide a background dose of insulin – are not always suitable for ...

Explore how stem cells transform when switching energy sources, leading to enhanced abilities and potential in regenerative ...

Instead, McDowell snagged an invite, through his friend Donald Trump Jr., to a falconry trip Kennedy hosted. On a sunny day ...

The cuts have hit most of the eight minority health offices across HHS, in many cases laying off the majority of workers, if ...

The Climate Status and Projections 2025 (KF25) has been developed and published by the Climate Council, Denmark’s independent ...

Wall Street steadies as GM, Honeywell earnings clash with tariff fears. Tech stocks face pressure ahead of key reports.